Background Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus that
causes a lifelong infection. Several diseases, including an aggressive form of leukaemia …

Objectives Human T‐lymphotropic virus (HTLV)‐1 causes T‐cell leukaemia and myelopathy.
Together with HTLV‐2, it is endemic in some African nations. Seroprevalence data from …

Introduction In resource-poor areas, infectious diseases may be important causes of
morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1) …

Background The Human T-Lymphotropic Virus type 1c subtype (HTLV-1c) is highly endemic
to central Australia where the most frequent complication of HTLV-1 infection in Indigenous …

Background In urban Guinea-Bissau, adults with a vaccinia scar had better survival but also
a higher prevalence of HIV-2 infection. We therefore investigated the association between …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …

Human T-lymphotropic viruses (HTLV) are Deltaretroviruses that infect millions of individuals
worldwide via the same transmission routes as HIV. With the aim of exposing the possible re …

Background HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult
population (5.2%) was observed in a rural area, Caió, in 1990. HIV-1 and HIV-2 are both …

This study aimed to describe the epidemiological, immunological and molecular features of
infection by the human T-lymphotropic virus-1/2 (HTLV-1/2) in individuals with HIV-1 in an …

Background Survival of people with HIV-2 and HTLV-1 infection is better than that of HIV-1
infected people, but long-term follow-up data are rare. We compared mortality rates of HIV-1 …